Page 2 - Achv News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Perkins Capital Management Inc. lessened its stake in Achieve Life Sciences, Inc. (NASDAQ:ACHV – Free Report) by 37.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 137,212 shares of the biopharmaceutical company’s stock after selling 80,888 shares during the quarter. […]

Achieve Life Sciences (NASDAQ:ACHV – Get Rating) had its price objective lowered by Lake Street Capital from $22.00 to $19.00 in a research note issued to investors on Wednesday morning, The Fly reports. Other equities research analysts also recently issued research reports about the stock. Maxim Group increased their target price on shares of Achieve […]

Achieve Life Sciences (NASDAQ:ACHV – Get Rating) had its target price reduced by Lake Street Capital from $22.00 to $19.00 in a report issued on Wednesday morning, The Fly reports. Several other research analysts have also recently weighed in on the stock. Oppenheimer reiterated an outperform rating and set a $17.00 price target on shares […]

Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) CEO John Bencich purchased 5,000 shares of the business’s stock in a transaction on Tuesday, May 30th. The stock was acquired at an average price of $5.50 per share, with a total value of $27,500.00. Following the purchase, the chief executive officer now directly owns 66,730 shares […]

Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) CEO John Bencich purchased 5,000 shares of the stock in a transaction that occurred on Tuesday, May 30th. The stock was bought at an average cost of $5.50 per share, with a total value of $27,500.00. Following the acquisition, the chief executive officer now owns 66,730 shares […]